title: Antisense oligonucleotide mediated exon skipping as a potential strategy for the treatment of a variety of inflammatory diseases such as rheumatoid arthritis.
authors.affiliation: Center for Human and Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands.
authors.forename: Seda
authors.initials: S
authors.lastname: Yilmaz-Elis
authors.forename: Annemieke
authors.initials: A
authors.lastname: Aartsma-Rus
authors.forename: Anne
authors.initials: A
authors.lastname: Vroon
authors.forename: Judith
authors.initials: J
authors.lastname: van Deutekom
authors.forename: Sjef
authors.initials: S
authors.lastname: de Kimpe
authors.forename: Peter A C
authors.initials: PA
authors.lastname: 't Hoen
authors.forename: Gert-Jan
authors.initials: GJ
authors.lastname: van Ommen
authors.forename: J Sjef
authors.initials: JS
authors.lastname: Verbeek
mesh_terms: D000818:Animals; D001172:Arthritis, Rheumatoid / Q000235:genetics / Q000628:therapy*; D003182:Complement C5 / Q000235:genetics / Q000378:metabolism; D005091:Exons / Q000235:genetics*; D015316:Genetic Therapy / Q000379:methods*; D006801:Humans; D053577:Interleukin-1 Receptor Accessory Protein / Q000235:genetics / Q000378:metabolism; D051379:Mice; D058990:Molecular Targeted Therapy / Q000379:methods; D016376:Oligonucleotides, Antisense / Q000627:therapeutic use*; D012326:RNA Splicing
chemical_list: D003182:Complement C5; C507765:IL1RAP protein, human; C507767:Il1rap protein, mouse; D053577:Interleukin-1 Receptor Accessory Protein; D016376:Oligonucleotides, Antisense